Emraclidine (CVL-231)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emraclidine (CVL-231), covering 2025-10-28 to 2025-10-28. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia [Phase 2]